Building Strategic Partnerships in Rare Diseases and Rare Cancers

Symbiose Innovation is interested in establishing strategic partnerships with organisations sharing the ambition to accelerate research, innovation and collaboration in rare diseases and rare cancers.

We are open to cooperating with universities, research centres, hospitals, clinical networks, patient organisations, foundations, biotechs, pharmaceutical companies, innovation hubs and other organisations active across the health research and innovation continuum.

Partnerships may focus on the development of joint initiatives, international network building, identification and mobilisation of complementary expertise, creation of collaborative communities, development of research and innovation projects, and joint promotion of scientific expertise, solutions and opportunities.

Symbiose Innovation can also contribute its expertise in the structuring, implementation and coordination of multi-stakeholder collaborations, helping partners transform shared interests into operational and sustainable initiatives.

Our objective is to create long-term connections between organisations and ecosystems and to facilitate cross-border collaborations that generate scientific, clinical and societal value for the rare disease and rare cancer communities.